Praxis Investment Management Inc. Has $248,000 Holdings in Avantor, Inc. $AVTR

Praxis Investment Management Inc. trimmed its position in shares of Avantor, Inc. (NYSE:AVTR) by 26.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,410 shares of the company’s stock after selling 6,710 shares during the quarter. Praxis Investment Management Inc.’s holdings in Avantor were worth $248,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Signaturefd LLC increased its holdings in Avantor by 19.8% during the 1st quarter. Signaturefd LLC now owns 5,470 shares of the company’s stock valued at $89,000 after purchasing an additional 904 shares in the last quarter. Truist Financial Corp increased its stake in shares of Avantor by 2.2% in the second quarter. Truist Financial Corp now owns 44,325 shares of the company’s stock valued at $597,000 after buying an additional 959 shares in the last quarter. Xponance Inc. increased its stake in shares of Avantor by 0.9% in the first quarter. Xponance Inc. now owns 114,422 shares of the company’s stock valued at $1,855,000 after buying an additional 966 shares in the last quarter. Louisiana State Employees Retirement System raised its holdings in shares of Avantor by 0.5% in the second quarter. Louisiana State Employees Retirement System now owns 191,700 shares of the company’s stock valued at $2,580,000 after buying an additional 1,000 shares during the last quarter. Finally, Nissay Asset Management Corp Japan ADV lifted its position in Avantor by 1.4% during the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 83,661 shares of the company’s stock worth $1,356,000 after buying an additional 1,138 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Insider Activity

In other news, CAO Steven W. Eck sold 3,476 shares of the firm’s stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the sale, the chief accounting officer owned 55,068 shares of the company’s stock, valued at $627,224.52. This trade represents a 5.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.20% of the stock is owned by company insiders.

Avantor Stock Up 1.7%

Shares of NYSE:AVTR opened at $14.82 on Monday. The company has a 50 day moving average price of $13.07 and a two-hundred day moving average price of $13.33. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.98. The company has a market capitalization of $10.10 billion, a PE ratio of 14.97, a PEG ratio of 4.83 and a beta of 0.98. Avantor, Inc. has a 52 week low of $10.82 and a 52 week high of $24.86.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a net margin of 10.31% and a return on equity of 11.39%. The firm had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm earned $0.25 EPS. Avantor’s quarterly revenue was down 1.1% on a year-over-year basis. Analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on AVTR. Barclays raised their price objective on shares of Avantor from $13.00 to $15.00 and gave the company an “overweight” rating in a research report on Thursday, October 2nd. Jefferies Financial Group reissued a “hold” rating on shares of Avantor in a report on Friday, August 1st. Raymond James Financial upped their price objective on Avantor from $14.00 to $16.00 and gave the stock an “outperform” rating in a report on Thursday. Stifel Nicolaus set a $12.00 price objective on Avantor and gave the company a “hold” rating in a research report on Monday, August 4th. Finally, JPMorgan Chase & Co. dropped their target price on Avantor from $17.00 to $14.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $15.81.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.